Shanghai Stock Exchange to Launch Two New Indices for Drug and Software Sectors in 2026
On September 24, the Shanghai Stock Exchange (SSE) and China Securities Index Co., Ltd. announced the launch of two new indices on September 29, 2026: the SSE Innovation Drug Sci-Tech Leading Index and the SSE STAR Market Software Services Index. Each index will select 40 securities from listed companies in their respective sectors, with the drug index drawing from both the STAR Market and main board, emphasizing high R&D and growth potential. The indices aim to provide diversified investment targets.
Reference imageEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Shanghai Stock Exchange to Launch Innovation Drug and Software Service Indices in 2026
On September 24, the Shanghai Stock Exchange (SSE) and China Securities Index Co., Ltd. announced that they will officially release two new indices on September 29, 2026: the SSE Innovation Drug Sci-Tech Leading Index and the SSE STAR Market Software Service Index. The Innovation Drug Sci-Tech Leading Index will select 40 listed companies from the SSE STAR Market and the main board that are in the innovative drug sector, characterized by high R&D levels and strong growth potential, with increased weight given to STAR Market samples. This index aims to reflect the overall performance of innovative drug companies on these boards. The SSE STAR Market Software Service Index will select 40 listed companies from the STAR Market in the fields of software development and software services, aiming to reflect the overall performance of software service companies on the STAR Market. The indices are designed to provide the market with more diversified investment targets.
Read sourceShanghai Stock Exchange to Launch Innovation Drug and Software Indices in 2026
On September 24, the Shanghai Stock Exchange (SSE) and the China Securities Index Company announced the upcoming launch of two new indices on September 29, 2026: the SSE Innovation Drug Sci-Tech Leading Index and the SSE STAR Market Software Services Index. The Innovation Drug index will select 40 securities from the STAR Market (科创板) and the SSE main board, focusing on companies with high R&D levels and strong growth in the innovative drug sector, with increased weighting for STAR Market samples. The Software Services index will select 40 securities from the STAR Market in software development and services. Both indices aim to provide investors with more diversified investment targets and reflect the overall performance of their respective sectors on the SSE and STAR Market.
Read sourceShanghai Stock Exchange to Launch Innovation Drug and Software Service Indices in 2026
The Shanghai Stock Exchange (SSE) and China Securities Index Co., Ltd. announced on an unspecified date that they will officially launch two new indices on September 29, 2026: the SSE Innovation Drug Sci-Tech Leading Index and the SSE STAR Market Software Service Index. The Innovation Drug index will select 40 listed companies from the SSE STAR Market (科创板) and the main board that are in the innovative drug sector, emphasizing high R&D capability and growth potential, with increased weighting for STAR Market constituents. The STAR Market Software Service Index will select 40 listed companies from the STAR Market in the software development and software services sectors. Both indices aim to provide investors with more diversified investment benchmarks and reflect the overall performance of their respective sectors.
Read sourceShow 2 older updatesHide older updates
Shanghai Stock Exchange to Launch Two New Indices in September 2026
The Shanghai Stock Exchange (SSE) and the China Securities Index Co., Ltd. announced that they will officially launch two new indices on September 29, 2026: the SSE Innovation Drug and Biomedical Leading Index and the SSE STAR Market Software Services Index. The move aims to provide the market with a richer set of investment targets, particularly focusing on the innovative pharmaceutical and software services sectors listed on the Shanghai Stock Exchange's Science and Technology Innovation Board (STAR Market). This development is part of ongoing efforts to expand the range of financial products available to investors in China's capital markets.
Shanghai Stock Exchange to Launch Two New Indices Including Innovative Drug Index
The Shanghai Stock Exchange and China Securities Index Co., Ltd. announced on September 24 that they will officially launch the SSE Innovative Drug Sci-Tech Leading Index and the SSE STAR Market Software Services Index on September 29, 2026. The SSE Innovative Drug Sci-Tech Leading Index will select 40 listed companies from the STAR Market and the main board of the Shanghai Stock Exchange that are in the innovative drug field, characterized by high research and development levels and strong growth potential. It will also increase the weight of STAR Market samples to reflect the overall performance of innovative drug companies in these sectors. The SSE STAR Market Software Services Index will select 40 listed companies from the STAR Market in areas such as software development and software services, aiming to reflect the overall performance of software service companies listed on the STAR Market. These indices are designed to provide the market with more diversified investment targets.
Read source